Environmental factors and their role in the transmission of SARS-CoV-2.
COVID-19
Environmental factors
SARS-CoV-2
Transmission of SARS-CoV-2
Journal
Biosafety and health
ISSN: 2590-0536
Titre abrégé: Biosaf Health
Pays: Netherlands
ID NLM: 101768009
Informations de publication
Date de publication:
Oct 2021
Oct 2021
Historique:
received:
26
03
2021
revised:
14
07
2021
accepted:
24
07
2021
pubmed:
18
8
2021
medline:
18
8
2021
entrez:
17
8
2021
Statut:
ppublish
Résumé
In December of 2019, several cases of atypical pneumonia caused by an unknown agent were reported in Wuhan, the capital city of Hubei Province in China. In early January 2020, it was announced that these cases were caused by a novel coronavirus. The virus was later named Severe Acute Respiratory Syndrome Coronavirus 2 (SARS-CoV-2), which causes a disease associated with atypical pneumonia termed Corona virus disease 2019 (COVID-19). Several respiratory viruses, including coronaviruses and influenza viruses tend to have prominent peaks of infection during colder seasons, especially in temperate regions. The cold temperatures, along with accompanying dry conditions can drive respiratory tract infections by assisting with viral transmission, weakening the human immune system, and increasing viral molecular stability. Though the topic of SARS-CoV-2 transmission and warm weather has been associated with misinformation campaigns, it is worth investigating since an informative answer may give an indication of the future behavior of SARS-CoV-2.
Identifiants
pubmed: 34401711
doi: 10.1016/j.bsheal.2021.07.005
pii: S2590-0536(21)00072-0
pmc: PMC8357490
doi:
Types de publication
Journal Article
Review
Langues
eng
Pagination
235-237Informations de copyright
© 2021 Chinese Medical Association Publishing House. Published by Elsevier BV.
Références
Clin Infect Dis. 2020 Dec 3;71(9):2482-2487
pubmed: 32472936
J Virol. 2014 Jul;88(14):7692-5
pubmed: 24789791
Cell Res. 2020 Mar;30(3):269-271
pubmed: 32020029
BMJ Open. 2021 Feb 17;11(2):e043863
pubmed: 33597143
Sci Rep. 2019 Jan 30;9(1):929
pubmed: 30700747
Lancet. 2020 Mar 28;395(10229):1063-1077
pubmed: 32145185
Expert Rev Anti Infect Ther. 2021 Jul;19(7):889-897
pubmed: 33270490
Emerg Infect Dis. 2020 Sep;26(9):
pubmed: 32579874
Sci Rep. 2020 Oct 12;10(1):17002
pubmed: 33046802
J Public Health Policy. 2006;27(1):2-12
pubmed: 16681184
Proc Natl Acad Sci U S A. 2009 Mar 3;106(9):3243-8
pubmed: 19204283
Nat Commun. 2020 May 29;11(1):2800
pubmed: 32472043
Rhinology. 2015 Jun;53(2):99-106
pubmed: 26030031
J Infect. 2019 Oct;79(4):373-382
pubmed: 31323249
Nat Med. 2020 Apr;26(4):502-505
pubmed: 32284613
Transbound Emerg Dis. 2021 Mar;68(2):296-312
pubmed: 32603505
JAMA Netw Open. 2020 Jun 1;3(6):e2011834
pubmed: 32525550